| Date Filed | Type | Description |
| 08/16/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $1.91, valued at
$19.1k
|
|
| 07/13/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 24,384 shares
@ $20.14, valued at
$491.1k
Sold 11,459 shares
@ $20.17, valued at
$231.1k
Sold 14,157 shares
@ $20.35, valued at
$288.1k
|
|
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $17.12, valued at
$79.2k
|
|
| 10/14/2022 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Exercised 11,100 options to buy
@ $1.91, valued at
$21.2k
|
|
| 04/15/2022 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 24,674 shares
@ $25.4247, valued at
$627.3k
Sold 44,793 shares
@ $26.5229, valued at
$1.2M
Sold 69,176 shares
@ $27.5277, valued at
$1.9M
|
|
| 04/07/2022 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 21,357 shares
@ $25.3418, valued at
$541.2k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
SC 13G/A
| Struthers Richard Scott reports a 4.2% stake in Crinetics Pharmaceuticals, Inc. |
| 09/09/2021 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $25, valued at
$250k
|
|
| 03/02/2021 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 294,000 options to buy
@ $15.29, valued at
$4.5M
|
|
| 02/05/2021 |
SC 13G/A
| Struthers Richard Scott reports a 5.1% stake in Crinetics Pharmaceuticals, Inc. |
| 12/04/2020 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $12.6, valued at
$12.6k
Bought 4,000 shares
@ $13.1, valued at
$52.4k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $22.61, valued at
$4.5M
|
|
| 02/11/2020 |
5
| Struthers Richard Scott (President & CEO) has filed a Form 5 on Crinetics Pharmaceuticals, Inc. |
| 02/11/2020 |
SC 13G
| Struthers Richard Scott reports a 6.1% stake in Crinetics Pharmaceuticals, Inc. |
| 08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2019 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 176,250 options to buy
@ $25.19, valued at
$4.4M
|
|
| 07/17/2018 |
3
| Struthers Richard Scott (See Remarks) has filed a Form 3 on Crinetics Pharmaceuticals, Inc. |